Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers.

Journal of gynecologic oncology - 1 Nov 2020

Ha Hyeong In, Ryu Jin Sun, Shim Hyoeun, Kong Sun Young, Lim Myong Cheol

Abstract excerpt

OBJECTIVE: We investigated the proportions of and reclassified BRCA1/2 variants of unknown significance (VUS) in Korean patients with epithelial ovarian, tubal, and primary peritoneal cancers. METHODS: Data from 805 patients who underwent genetic testing for BRCA1/2 from January 1, 2006 to August 31, 2018 were included. The VUS in BRCA1/2 were reclassified using the 2015 American College of Medical Genetics and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fallopian Tube Neoplasms

Share to Fallopian Tubes

Share to Genetic Predisposition to Disease

Share to Genetic Variation

Share to Ovarian Neoplasms

Share to Peritoneal Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33078592
DOI: 10.3802/jgo.2020.31.e83
PMCID: PMC7593220

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers.PMID 33078592Read ↗

Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer.Semantic proximity Read ↗

A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.Semantic proximity Read ↗

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.Semantic proximity Read ↗

Analysis of BRCA1/2 variants of unknown significance in patients with breast cancer from a prospective KOHBRA studySemantic proximity Read ↗

Cancer Incidence Rates Between BRCA1/2 Pathogenic Variant Carriers and Non-Carriers in Real-World Clinical Practice.Semantic proximity Read ↗

Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.Semantic proximity Read ↗

Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.Semantic proximity Read ↗

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.Semantic proximity Read ↗

Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer.Semantic proximity Read ↗

Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.